JAKARTA/KUALA LUMPUR -- Indonesia and Malaysia are scurrying to beef up their capabilities to treat and stop COVID-19, as their infection trajectories raise alarm.
For Indonesia, which is still logging over 4,000 cases a day, Thursday brought the introduction of the antiviral drug known as remdesivir. The same day, Malaysia's science minister revealed his country is negotiating with numerous vaccine manufacturers, just hours before health authorities reported the highest daily infection count since June.
